In hypertensive patients, alterations in the haematocrit, plasma viscosity, erythrocyte aggregation tendency and deformability in concert cause an increased blood viscosity. 1 In healthy subjects, correlations between the whole blood viscosity and insulin resistance have been found. 2 The aim of the present study was to identify correlations between the different factors determining the whole blood viscosity and metabolic variables in hypertensive patients. Moreover, we wanted to elucidate the impact of acute hyperinsulinaemia on the flow properties of blood.
Patients with essential hypertension were recruited through advertisements in local newspapers to a clinical trial of an antihypertensive drug. Thirteen of these patients agreed to participate in the present investigation. The patient interview, physical examination, laboratory investigation (serum electrolytes and creatinine) were especially focused in order to discover secondary hypertension. Hormonal analysis or radiographical examinations were carried out only if secondary hypertension was likely.
All prior antihypertensive medication was discontinued, and the patients received placebo for 4 -6 weeks. Patients were included in the study if, at the end of the placebo phase, they showed a supine diastolic blood pressure (BP) between 95 and 115 mm Hg on two separate consecutive occasions.
The group comprised 10 males and three females with a mean age of 60 ± 7 years. Their body mass index was 27 ± 4 kg/m 2 . Before the clamp procedure a systolic BP, diastolic BP and mean arterial pressure (MAP) of 167 ± 18, 102 ± 5 and 124 ± 9 mm Hg were measured.
The investigations were performed after an overnight fast at the end of the placebo period. Insulin was measured using a commercial radioimmunoassay kit. Insulin sensitivity was evaluated with the euglycaemic insulin clamp procedure. Glucose disposal was calculated as the amount of glucose infused per minute and kg body weight (mg/kg/min) and expressed as the M-value derived from the glucose uptake during the last 60 min of the clamp.
MAP was calculated as the diastolic pressure plus one-third of the pulse pressure. Body mass index (BMI) was defined as body weight in kilograms divided by squared length in metres. The haematocrit was analysed by micro-haematocrit centrifugation without correction for trapped plasma.
Haemorheological variables were assessed using previously described methods. 1 In short, the measurements were made at 37°C in a Low Shear 30 rotational viscometer (Contraves AG, Zü rich, Switzerland). A shear rate of 38 per second and 100 per second were used for plasma and whole blood viscosity respectively. Erythrocyte aggregation tendency was measured as the whole blood viscosity at a shear rate of 1 per second, corrected for patient haematocrit and plasma viscosity. Erythrocyte deformability was assessed as the fluidity, ie, the inverted value of viscosity, of erythrocytes separated from plasma and buffy coat and resuspended to a haematocrit of 55%.
Haemorheology was evaluated in all the patients before the initiation of the insulin clamp but, for practical reasons, in only nine of the hypertensives after 2 h of hyperinsulinaemia.
Values are given as means ± s.d.
Paired two tailed t-tests, simple and stepwise multiple regression analysis were used. The level of statistic significance was set at P Ͻ 0.05. The fasting insulin and blood glucose before the clamp were 11 ± 3 mU/L and 5.3 ± 0.5 mmol/L respectively. A M-value at clamp on 5.5 ± 1.7 mg/kg/min was calculated. Stepwise multiple regression analyses were performed between the haemorheological variables (haematocrit, whole blood and plasma viscosity, erythrocyte aggregation tendency and fluidity) and the other variables measured (BMI, MAP, fasting glucose, fasting insulin and M-value at clamp). When the whole blood viscosity was used as the dependent variable the Mvalue (F = 10.3, P Ͻ 0.05, Figure  1 ) and MAP (F = 7.6, P Ͻ 0.01) remained significant (model R 2 and P, 0.6 and Ͻ0.01, respectively). Only fasting insulin remained correlated with erythrocyte fluidity (R = −0.82, P Ͻ 0.001, Figure 2 ). No variables remained correlated with the haematocrit, plasma viscosity or aggregation tendency.
Two hours after the start of the clamp an insulin concentration of 99 mU/L was reached. At this time-point the haematocrit (42.0 ± 2.7 vs 40.9 ± 2.5%, P Ͻ 0.05), plasma viscosity (1.27 ± 0.06 vs 1.23 ± 0.05 mPa/s, P Ͻ 0.05) and erythrocyte fluidity (95 ± 7 vs 91 ± 9 1/Pa/s P Ͻ 0.01) had decreased whereas the whole blood viscosity (4.3 ± 0.3 vs 4.2 ± 0.3 mPa/s) and the erythrocyte aggregation (1.1 ± 0.04 vs 1.1 ± 0.1) tendency had remained unchanged.
Our finding of a correlation between the whole blood viscosity and the degree of insulin resistance in hypertensive patients confirms previous observations made in healthy young men 2 and in normotensive and hypertensive premenopausal women. 3 In hypertensive patients, an increased whole blood viscosity is accompanied by an increased total peripheral flow resistance 1 which may decrease blood flow in skeletal muscle and thereby the cellular exposure to insulin, with a possible contribution to insulin resistance. This suggestion finds support in studies showing an association between decreased limb skeletal muscle blood flow and insulinmediated glucose uptake in obesity, 4 and in hypertension. 5 The present study showed that elevated plasma insulin in hypertensive subjects was associated with a decreased erythrocyte fluidity and that an acute induction of hyperinsulinaemia further decreased this factor of importance for normal haemorheology. Erythrocyte fluidity has been shown to reflect erythrocyte deformability. 6 Since the diameter of a red blood cell exceeds that of the smallest capillaries, erythrocyte deformation is of vital importance. A decreased erythrocyte deformability would give rise to an increased flow resistance in the micro-circulation. In subjects with fasting hyperglycaemia, micro-vascular dysfunction was associated with the degree of insulin resistance and correlated to fasting plasma insulin. 7 Insulin-induced alterations in the mechanical properties of the red blood cells may have contributed to these relationships.
An increased intracellular concentration of free calcium ions is associated with a decreased erythrocyte deformability. 8 In vitro insulin has been shown to cause an accumulation of Ca 2+ ions in red blood cells. 9 Accumulation of calcium ions may thus explain the negative correlation between fasting insulin and erythrocyte fluidity and the decrease in fluidity after acute elevation of plasma insulin.
Based on the observations that erythrocyte fluidity correlated inversely with fasting insulin and decreased acutely during hyperinsulinaemia, we conclude that insulin is an important factor as regards the regulation of erythrocyte deformability in hypertensive patients. High circulating levels of insulin may cause impaired erythrocyte deformability and thereby increased flow resistance in the micro-circulation in these patients. Hypothesis that insulin resistance has a haemodynamic basis supports our finding of a correlation between the degree of increase in whole blood viscosity and the decrease in glucose disposal. 
